Obesity and menopause modify the epigenomic profile of breast cancer.

Obesity is a high risk factor for breast cancer. This relationship could be marked by a specific methylome. The current work was aimed to explore the impact of obesity and menopausal status on variation in breast cancer methylomes. Data from Infinium 450K array-based methylomes of 64 breast tumors were coupled with information on BMI and menopausal status. Additionally, DNA methylation results were validated in 18 non-tumor and 81 tumor breast samples. Breast tumors arising in either pre- or postmenopausal women stratified by BMI or menopausal status alone were not associated with a specific DNA methylation pattern. Intriguingly, the DNA methylation pattern identified in association with the high-risk group (postmenopausal women with high BMI (>25) and premenopausal women with normal or low BMI < 25) exclusively characterized by hypermethylation of 1287 CpG sites as compared with the low-risk group. These CpG sites included the promoter region of fourteen protein-coding genes of which CpG methylation over the ZNF577 promoter region represents the top scoring associated event. In an independent cohort, the ZNF577 promoter methylation remained statistically significant in association with the high-risk group. Additionally, the impact of ZNF577 promoter methylation on mRNA expression levels was demonstrated in breast cancer cell lines after treatment with a demethylating agent (5-azacytidine). In conclusion, the epigenome of breast tumors is affected by a complex interaction between BMI and menopausal status. The ZNF577 methylation quantification is clearly relevant for the development of novel biomarkers of precision therapy in breast cancer.

[1]  F. Nuttall,et al.  Body Mass Index , 2020, Definitions.

[2]  R. Goldbohm,et al.  The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors , 2015, Breast Cancer Research and Treatment.

[3]  Jacob C. Seidell,et al.  The Global Burden of Obesity and the Challenges of Prevention , 2015, Annals of Nutrition and Metabolism.

[4]  Han Liu,et al.  NADPH oxidases and cancer. , 2015, Clinical science.

[5]  Youping Deng,et al.  A seven-gene CpG-island methylation panel predicts breast cancer progression , 2015, BMC Cancer.

[6]  E. Levy,et al.  Oxidative stress and DNA methylation regulation in the metabolic syndrome. , 2015, Epigenomics.

[7]  F. Casanueva,et al.  Obesity and the reproductive system disorders: epigenetics as a potential bridge. , 2015, Human reproduction update.

[8]  A. Olshan,et al.  Body Mass Index Is Associated with Gene Methylation in Estrogen Receptor–Positive Breast Tumors , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[9]  Juan Sandoval,et al.  A DNA methylation‐based definition of biologically distinct breast cancer subtypes , 2014, Molecular oncology.

[10]  H. Chu,et al.  DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival , 2014, Breast Cancer Research.

[11]  C. Gieger,et al.  DNA methylation and body-mass index: a genome-wide analysis , 2014, The Lancet.

[12]  V. Kutala,et al.  Molecular insights into the association of obesity with breast cancer risk: relevance to xenobiotic metabolism and CpG island methylation of tumor suppressor genes , 2014, Molecular and Cellular Biochemistry.

[13]  Manel Esteller,et al.  Epigenetic modifications in breast cancer and their role in personalized medicine. , 2013, The American journal of pathology.

[14]  E. Tokar,et al.  Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation , 2013, Epigenetics.

[15]  F. Milagro,et al.  Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. , 2013, Molecular aspects of medicine.

[16]  M. Esteller,et al.  Epigenetic profiling joins personalized cancer medicine , 2013, Expert review of molecular diagnostics.

[17]  M. Ganfornina,et al.  The thiazole derivative CPTH6 impairs autophagy , 2013, Cell Death and Disease.

[18]  F. Casanueva,et al.  Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer , 2013, Free radical research.

[19]  F. Milagro,et al.  CLOCK, PER2 and BMAL1 DNA Methylation: Association with Obesity and Metabolic Syndrome Characteristics and Monounsaturated Fat Intake , 2012, Chronobiology international.

[20]  Michael Rehli,et al.  Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Alfonso Valencia,et al.  Distinct DNA methylomes of newborns and centenarians , 2012, Proceedings of the National Academy of Sciences.

[22]  M. Lerman,et al.  Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays , 2012, Epigenetics.

[23]  F. Casanueva,et al.  Association of breast cancer and obesity in a homogeneous population from Spain , 2012, Journal of Endocrinological Investigation.

[24]  N. Joste,et al.  Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers , 2012, PloS one.

[25]  S. Edge,et al.  Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. , 2011, The American journal of clinical nutrition.

[26]  J. Martín-Subero,et al.  Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation , 2011, Journal of Clinical Pathology.

[27]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[28]  C. Ricketts,et al.  Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.

[29]  Sambasivarao Damaraju,et al.  Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility , 2011, Human Genetics.

[30]  J. Borén,et al.  Ablation of the very‐long‐chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet‐induced obesity , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  J. Shao,et al.  Role of adipocytokines in obesity-associated insulin resistance. , 2008, The Journal of nutritional biochemistry.

[32]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[33]  S. Belinsky,et al.  Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. , 2008, Cancer research.

[34]  S. Sukumar,et al.  Molecular links between obesity and breast cancer. , 2006, Endocrine-related cancer.

[35]  E. Scarano,et al.  DNA Methylation , 1973, Nature.

[36]  A. Neugut,et al.  Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity. , 2015, International journal of cancer and clinical research.

[37]  C. Hudis,et al.  Molecular Pathways Molecular Pathways : Adipose In fl ammation as a Mediator of Obesity-Associated Cancer , 2013 .

[38]  Kemp H. Kernstine,et al.  DNA methylation biomarkers for lung cancer , 2011, Tumor Biology.

[39]  S. Falcon,et al.  BIOINFORMATICS APPLICATIONS NOTE Systems biology , 2005 .

[40]  Who Consultation on Obesity.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.